Mubadala’s Kelix Bio to Acquire Four Pharma Assets from GHH
Kelix Bio, a Mubadala-backed pharmaceutical company, is moving to acquire four major assets from Yas Holding’s GlobalOne Healthcare Holding (GHH) in a strategic deal that …
Kelix Bio, a Mubadala-backed pharmaceutical company, is moving to acquire four major assets from Yas Holding’s GlobalOne Healthcare Holding (GHH) in a strategic deal that …
Mubadala’s healthcare arm, KELIX Bio, has made a decisive step in boosting its presence in the life sciences sector by acquiring four pharmaceutical assets from …
Arabian Post Staff -Dubai Mubadala Investment Company, in collaboration with CBC Group, has taken full control of UCB Pharma’s mature business in China. This strategic …
New agreement marks major milestone for Zuellig Pharma as it focuses on expanding its consumer healthcare segment, and for Institut AllergoSan as it expands its …
The Supreme Court said on Thursday that members of the Sackler family cannot be shielded from liability for civil claims related to the opioid epidemic, …
Unveiling Groundbreaking Research and Product Development to Reduce Antibiotic Use in Digestive and Respiratory Care HANOI, VIETNAM – Media OutReach Newswire – 17 May 2024 …